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O B J E C T I V E S The purpose of this study was to evaluate whether the addition of a contrast agent to
dobutamine stress echocardiography (DSE) improves its diagnostic accuracy for coronary artery disease (CAD)
and to determine the effect of image quality on the diagnostic impact of contrast agent use in this setting.
B A C KG ROUND Contrast agents can improve endocardial border deﬁnition. To date, however,
there are no randomized trials that have evaluated the impact of contrast agent use on the accuracy of DSE.
METHOD S Patients referred for stress testing with dobutamine echocardiography underwent 2 DSE
studies: 1 with and 1 without a contrast agent, at least 4 h apart in a randomized order andwithin a 24-h period.
R E S U L T S A total of 101 patients underwent both DSE studies. Similar hemodynamics were achieved
during the 2 stress testing sessions. The use of a contrast agent improved the percentage of segments
adequately visualized at baseline (from 72  24% to 95  8%) and more so at peak stress (67  28%
to 96  7%); both p  0.001. Interpretation of wall motion with high conﬁdence also increased with
contrast agent use from 36% to 74% (p  0.001). Segment visualization with the use of a contrast agent
improved in all views, but was more pronounced in the apical views. In unenhanced DSE, 36% of studies
were normal, 51% had ischemia, and 8% were uninterpretable—all of which became interpretable with
the use of a contrast agent. When compared with angiography (n  92; 55 patients with CAD), accurate
detection of ischemia was higher with contrast-enhanced studies versus nonenhanced studies (p 
0.02). As endocardial visualization and conﬁdence of interpretation decreased in unenhanced studies, a
greater impact of the use of a contrast agent on DSE accuracy was observed (p  0.01).
CONC L U S I O N S During dobutamine stress echocardiography, contrast agent administration
improves endocardial visualization at rest and more so during stress, leading to a higher conﬁdence of
interpretation and greater accuracy in evaluating CAD. The lesser the endocardial border visualization,
the higher the impact of contrast echocardiography on accuracy. (J Am Coll Cardiol Img 2008;1:
145–52) © 2008 by the American College of Cardiology Foundation
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146harmacologic stress testing is a versatile
method for identifying patients with coro-
nary artery disease (CAD) and determining
prognosis (1–6). Although harmonic imaging
as improved image quality, interpretation of stress
chocardiograms may still be limited in patients
ith poor acoustic windows (7). With the advent of
ntravenous contrast agents, further improvement in
mage quality and endocardial border definition is
ow possible, which can enhance interpretation of
egional and global function (8,9). There is a
aucity of data regarding the use of contrast agents
n stress echocardiography. Previous investigations
ave demonstrated that contrast agents improved
See page 153
isualization of dobutamine stress echocardiogra-
hy (DSE) images and confidence of interpretation
10–13) and resulted in less use of radionuclide
testing (14). To date, however, there are
no trials that have shown an increased
accuracy of contrast-enhanced DSE in the
detection of CAD in the same patients.
Furthermore, there are currently no data
regarding the threshold of when to use
contrast agents in this setting, resulting in
the wide variability of contrast agent use in
stress echocardiography laboratories. Ac-
cordingly, the present study was designed
to evaluate the impact of an intravenous
contrast agent on the diagnostic accuracy
of DSE in comparison with the angio-
graphic standard in an unselected popula-
ion with regard to image quality. The effect of
ontrast agent enhancement on endocardial visual-
zation, confidence of interpretation, and on the
ccuracy of DSE in relation to image quality was
ssessed.
ETHODS
atient population. Patients with intermediate to
igh probability of CAD based on clinical param-
ters and risk factors, referred to the participating
chocardiography laboratories for DSE, were eval-
ated for enrollment into the study (15). The
nvolved sites were those of the Methodist DeBakey
eart Center, the Ben Taub General Hospital, the
eterans Affairs Medical Center, and the Baylor
eart Clinic in Houston, Texas. By design, patients
nderwent 2 DSE studies, 1 with and 1 without a
se
ing
rontrast agent. Patients were not screened for image Muality to allow evaluation of the impact of the use
f a contrast agent on accuracy in the whole
pectrum of image quality. Patients were excluded if
hey had history of a recent myocardial infarction
within 1 week), left ventricular (LV) systolic dys-
unction (ejection fraction 40%), severe valvular
egurgitation or stenosis, unstable angina, heart
ailure (New York Heart Association functional
lass III or IV), ventricular tachycardia, systolic
lood pressure 90 or 180 mm Hg, or if they
lected not to participate. The protocol was ap-
roved by the Institutional Review Board of Baylor
ollege of Medicine and the affiliated hospitals.
nformed written consent was obtained from all
atients.
SE tests. The study was a prospective randomized
ross-over trial. The patients underwent 2 DSE
tudies: 1 with and 1 without a contrast agent. The
rder of the 2 tests was randomized, and they were
erformed at least 4 h apart within a period of 24 h.
ardiovascular medications were not withheld be-
ore the tests, as is routinely accepted. The ultra-
ound systems used for acquisition of images were a
ewlett Packard Sonos 5500 (Andover, Massachu-
etts), an Acuson Sequoia (Mountain View, Cali-
ornia) or an Advanced Technology Laboratories
Bothel, Washington) system. To control for
onographer variability in image acquisition, the
ame sonographer performed both noncontrast and
ontrast agent DSE studies for a particular subject.
armonic imaging was used for both studies.
ONCONTRAST DSE. Baseline images were ob-
ained in the standard parasternal and apical views.
n infusion of dobutamine was started at 5 g/kg/
in and increased every 3 min to 10, 20, 30, and 40
g/kg/min until the target heart rate was achieved.
tropine in 0.25-mg doses up to a total dose of 1
g was given if the heart rate reached was85% of
he age-predicted maximal heart rate. The dobut-
mine infusion was stopped if the target heart rate
as achieved or for other routine safety measures.
mages at baseline, 5 and 10 g/kg/min, and
aximal dobutamine infusion from the parasternal
nd apical views were digitized online and stored.
ONTRAST AGENT DSE. The stress protocol de-
cribed above for the noncontrast DSE was also
ollowed for the contrast-enhanced DSE. B-mode
armonic imaging along with a mechanical index
etween 0.3 and 0.5 for best LV opacification with
contrast agent and endocardial border definition
as used. The contrast agent (Definity, Bristol-B B R E V I A T I O N S
N D A C R O N YM S
AD coronary artery disea
X circumflex artery
SE dobutamine stress
chocardiography
EE general estimating
quation
AD left anterior descend
rtery
V left ventricle/ventriculayers Squibb Medical Imaging, North Billerica,
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147assachusetts) was reconstituted with normal sa-
ine to form a total volume of 10-ml solution.
oluses of 0.5 to 1 ml of the diluted contrast agent
ere given at each stage when images were to be
igitized (rest, 5 and 10 /kg/min, and peak dose),
o that all images to be interpreted were enhanced
ith the contrast agent.
chocardiographic analysis. DSE INTERPRETATION.
he echocardiographic images were interpreted by
single experienced observer (W.A.Z.), blinded to
ll data, in a random order over a 2-month period.
egional LV wall motion was scored at baseline,
ow dose, and maximum dose in a 17-segment
Table 1. Patient Demographics
Characteristics
n 108
Age, yrs (range) 59.6 9 (29–85)
Gender, male/female 80/28
Weight, kg (range) 92.0 23.6 (45–199)
Medical history
Hypertension 81 (75%)
Diabetes 43 (40%)
Hyperlipidemia 79 (73%)
Smoking 477 (44%)
Previous coronary bypass
surgery
9 (8%)
Previous myocardial infarction 30 (28%)
Previous percutaneous coronary
intervention
14 (13%)
Congestive heart failure 24 (22%)
Medications
Angiotensin II receptor blocker 3 (3%)
ACE inhibitor 59 (55%)
Alpha-blocker 3 (3%)
Beta-blocker 70 (65%)
Diuretic 21 (19%)
Nitrates 52 (48%)
Cholesterol-lowering drug 88 (81%)
Values are represented as n (%) unless otherwise indicated.
ACE  angiotensin-converting enzyme.
Table 2. Hemodynamics During Stress Testing and DSE Parame
Rest heart rate (beats/min)
Maximal heart rate (beats/min)
Rest SBP (mm Hg)
Maximal SBP (mm Hg)
Percentage of patients achieving 85% target heart rate
Maximal dose of dobutamine (g/kg/min)
Atropine dose (mg)DSE  dobutamine stress echocardiography; SBP  systolic blood pressure.odel (16). A segment was defined as normal if it
ad normal function at rest and improved function
uring stress, as ischemic if the segment developed a
ew wall motion abnormality or worsening of
esting hypokinesia, and as scar if there was a wall
otion abnormality at rest without development of
schemia. The interpretation scheme of normal,
schemia, and scar was given for the study as a
hole, as well as for each of the individual coronary
rtery territories of the left anterior descending
rtery (LAD), circumflex artery (CX), and right
oronary artery (RCA), and for non-LAD territory
RCA and CX), as overlap in these territories
requently occurs (16). The interpretation was
ased on the integration of all of the available views
or the individual territories.
ISUALIZATION OF ENDOCARDIUM. Visualization
f the endocardium was scored for each segment:
 adequate or excellent endocardium, 2  in-
omplete endocardial border, 3  epicardial border
nly, 4  not visible (correct view, but not seen), 5
not obtained (out of plane or foreshortened), and
 contrast attenuation (in contrast agent studies).
f a segment was visualized from more than 1 view,
he best visualization score was used. Any endocar-
ial visualization was the combination of scores 1
nd 2; segments with a score 2 were considered
onvisualized.
ONFIDENCE OF INTERPRETATION. Confidence of
nterpretation of regional wall motion was scored
or each segment: 1  high, 2  medium, and 3 
ow. An overall confidence of interpretation for
oronary territories and for global interpretation
as also scored (1  high, 2  medium, and 3 
ow).
uantitative coronary angiography. Coronary an-
iography was performed using the Judkins tech-
ique within 30 days of study enrollment. Subjects
ith myocardial infarction or revascularization be-
No
Contrast Contrast
p
Value
68 12 71 13 0.03
140 13 141 10 0.57
132 19 130 18 0.36
152 28 154 28 0.29
71% 73% 1.00
39 7 38 6 0.20
0.5 0.6 0.4 0.5 0.74ters
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148ween tests were excluded. Quantitative angiogra-
hy was performed by an independent observer
sing the CASS (Cardiovascular Angiographic
nalysis System) system (PIE Medical Instru-
ents, Maastricht, the Netherlands). Significant
oronary artery stenosis was defined as 70% nar-
owing of the reference lumen diameter.
tatistical analysis. Continuous variables are ex-
ressed as mean  SD. The adequacy of visualiza-
ion of myocardial segments is expressed as a
ercentage of total segments. The percentage of
egments visualized in contrast-enhanced studies
as compared to noncontrast studies using paired t
est. Sensitivity, specificity, and diagnostic accuracy
ere determined in interpretable studies using stan-
ontrast Agent Use on Visualization of Segments and
etation
rast agent, an increase in percentage of segments with excellent
ial visualization (score 1) is seen. Furthermore, the distribution of
ce of interpretation was different, with a much larger percentage
with high conﬁdence when the contrast agent was added.
n of Segments by View at Peak Stress: Contrast Agent Versus
ment
rast agent, an increase in percentage of segments with excellent
ial visualization (score 1) was seen in all echocardiographic views,
the apical views. PLA  parasternal long axis; SAX  short axis;(
chambers.ard definitions for patients (any disease present)
nd by individual respective coronary territory.
oncordance of agreement with angiography (ac-
uracy) between contrast-enhanced and unen-
anced DSE studies was calculated using the Mc-
emar test. A general estimating equation (GEE)
epeated measures analysis was performed to check
or order effects of the test (contrast-agent first
roup and contrast-agent second group). Statistical
ignificance was set at a p value 0.05.
E SULTS
atient population. One hundred eight patients
ere recruited (Table 1); 91 had a history of chest
ain. The baseline ejection fraction was 56.2 
.8%. A total of 101 patients completed the 2
SE studies, and 92 had a cardiac catheteriza-
ion, 74% of which were performed after the echo
tudies: 18 patients (19%) had 1-vessel, 22 (24%)
ad 2-vessel, and 12 (13%) had 3-vessel, or left
ain, disease. A total of 87 patients completed all
he studies.
emodynamics during DSE. Hemodynamics were
omparable between the 2 tests (Table 2). Stress-
nduced ischemia on the electrocardiogram was
imilar in both DSE studies (23% in each). Adverse
vents were reported in 10% of either group, the
ajority of which were chest pain (6% in the
ontrast-agent group and 4% in the noncontrast
roup). There were no serious adverse events.
isualization of endocardium and conﬁdence of inter-
retation. The contrast agent increased endocardial
isualization at rest and particularly during maximal
tress. All contrast-enhanced studies were interpret-
ble, whereas 8 (8%) of unenhanced studies were
ninterpretable. The percentage of segments with
xcellent or adequate visualization (score 1) in-
reased with the use of a contrast agent at rest and
ore so at maximal stress (Fig. 1). The percentage
f segments with any endocardial visualization
score 1 or 2) also increased with the use of a
ontrast agent at rest from 92  11% to 98  4%
nd at maximal stress from 89  16% to 99  4%.
he GEE repeated measures analysis did not reveal
ny effect of the order of the test on the results
bserved. Figure 2 summarizes the impact of con-
rast agent use on endocardial visualization (score 1)
t peak stress from the different views. Whereas the
mpact was observed in all views, it was more
ronounced in the apical views. Similar observa-
ions were noted for any endocardial visualizationFigure 1. Impact of C
Conﬁdence of Interpr
With the use of a cont
or adequate endocard
the degree of conﬁdenFigure 2. Visualizatio
Noncontrast Enhance
With the use of a cont
or adequate endocard
with a larger impact inscore 1 or 2): the percentage of segments increased
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149rom a range of 85% to 91% without a contrast
gent, to 96% to 100% with a contrast agent.
ontrast agent administration improved the overall
onfidence of interpretation of the studies (Fig. 1,
ight panel). The change in confidence of interpre-
ation was better with the use of a contrast agent in
3% of patients, the same in 40%, and worse in 7%
f patients, the latter mostly because of attenuation.
xamples of the effect of the use of a contrast agent
n segment visualization and study interpretation
re shown in Figures 3 and 4.
etection of CAD in enhanced and nonenhanced DSE
tudies in the total population. In the unenhanced
tudies, the overall distribution of results was nor-
al in 36%, ischemia in 50%, scar in 6%, and
ninterpretable in 8%. This distribution was differ-
nt in contrast-enhanced studies: normal in 40%,
Figure 3. Example of the Effect of Contrast Agent Use on DSE i
Quad-screens of end-systolic frames from the 4-chamber view of no
Video 1) and contrast-enhanced images (right) (Online Video 2) are
identiﬁed an apical ﬁxed wall motion abnormality. Contrast agent e
the identiﬁcation of ischemia in the lateral wall and apex (arrows) a
DSE  dobutamine stress echocardiography.
Figure 4. Example of the Effect of Contrast Agent Use on DSE i
Quad-screens of end-systolic frames of noncontrast (Online Video 3
diographic (DSE) images from the short axis. Noncontrast images ar
image quality and endocardial border deﬁnition in certain regions.
both DSE studies.n a Patient With Suboptimal Endocardial Visualization
ncontrast dobutamine stress echocardiographic images (left) (Online
shown. Noncontrast images had signiﬁcant endocardial dropout and
nhancement clearly delineated the endocardial segments and allowed
s well as dilation of the ventricle at end-systole at maximal stress.n a Patient With Excellent Endocardial Visualization
) and contrast-enhanced (Online Video 4) dobutamine stress echocar-
e of excellent quality. Contrast agent administration decreased the
Still, ischemia was observed in the inferoposterior wall (arrows) inschemia in 55%, and scar in 5% (p  0.01). TheFigure 5. Impact of Contrast Agent Use on Accuracy of DSE in Relation to
Conﬁdence of Interpretation in Unenhanced DSE Studies
There was no impact of contrast agent use on the agreement of dobutamine stress
echocardiography (DSE) with angiography (accuracy) if the conﬁdence of interpretation
was high in unenhanced studies. However, a signiﬁcant impact was seen when the con-
ﬁdence of interpretation was low, with an intermediate effect in studies with medium
conﬁdence.
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150verall concordance of agreement on the presence
r absence of CAD with coronary angiography was
7% for unenhanced studies and increased to 68%
ith contrast enhancement (p  0.06). The
ensitivity and specificity for CAD in unen-
anced DSE studies that could be interpreted
ere 75% and 51%, respectively. With the use of
contrast agent, sensitivity and specificity increased
o 80% and 55%, respectively, but did not reach
tatistical significance. Accurate detection of isch-
mia versus no ischemia was higher with the use of
contrast agent (66% vs. 53%) (p  0.02). Agree-
ent for detection of ischemia versus no ischemia
as similar for LAD distribution between unen-
anced and enhanced DSE (57% vs. 53%, respec-
ntrast Agent Use on the Sensitivity and Speciﬁcity of DSE
agent use on the sensitivity and speciﬁcity of dobutamine stress
) for coronary artery disease is shown, grouped by conﬁdence of
anced studies. Only interpretable studies are included in the
een mostly for improvement in speciﬁcity in low- to medium-
a lesser improvement in sensitivity, and a trend for worsening in
d in unenhanced studies interpreted with high conﬁdence.
ntrast Agent Use on Accuracy of DSE in Relation to the
Visualized
the use of a contrast agent on accuracy of dobutamine stress
) was seen when 2 myocardial segments were not visualized in
esser impact was seen when 1 to 2 segments were not seen, andt
d if all segments were already visualized.ively; p  0.3) but was significantly higher for CX
62% vs. 49%; p  0.0009), RCA (63% vs. 54%;
 0.088), and CX or RCA territories (64% vs.
2%; p  0.016).
elation of segment visualization and conﬁdence of
nterpretation to impact of contrast agent enhance-
ent on DSE accuracy. The agreement of detection
f CAD with angiography was compared depend-
ng on confidence of interpretation in unenhanced
tudies (Fig. 5). In studies interpreted with high
onfidence, there was no impact attributable to
ontrast agent use. A significant impact of contrast
gent use was seen in studies with low confidence
68% vs. 36%; p  0.01), with a similar trend
tarting in the medium confidence group. In the
igh confidence group, sensitivity and specificity for
etection of CAD were similar in contrast-
nhanced versus nonenhanced studies. In low and
edium confidence interpretation, there was a
rend for improvement in both sensitivity and
pecificity (Fig. 6).
Lower confidence of interpretation in unen-
anced studies was associated with a lower number
f visualized segments. The number of segments
ith any endocardial visualization (score 1 and 2)
as 16.8  1.0, 16.0  1.2, and 11.8  2.9
egments in the groups with high, medium, and low
onfidence of interpretation, respectively. The effect
f worsening extent of nonvisualized segments on
ccuracy of interpretation and the impact of the use
f a contrast agent in this setting were evaluated
Fig. 7). There was no impact of contrast agent use
f all 17 segments were visualized (p  0.36). On
he other hand, a significant impact of contrast
gent enhancement was seen in patients with 2
onvisualized segments (59% vs. 28%; p  0.005),
ith a similar trend in the intermediate group.
I SCUS S ION
he present study demonstrates the impact of
ontrast agent enhancement on the accuracy of
tress echocardiography in the diagnosis of CAD
nd in the same population. The worse the extent of
ndocardial visualization—and hence confidence of
nterpretation—the higher the impact of contrast
gent use on the accuracy of DSE.
mpact of contrast enhancement in stress echocardio-
raphy. Although overall good sensitivity and spec-
ficity are reported for DSE in detecting CAD (1),
ultiple factors may produce suboptimal image
uality that can result in nondiagnostic studies in upFigure 6. Effect of Co
The effect of contrast
echocardiography (DSE
interpretation in unenh
analysis. A trend was s
conﬁdence studies andFigure 7. Effect of Co
Number of Segments
A signiﬁcant impact of
echocardiography (DSE
unenhanced studies. Lo 33% of patients (14,17). In the present study, the
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151dministration of a contrast agent during DSE
mproved endocardial border definition at rest and
uring stress. This was observed in all tomographic
iews, particularly from the apex, and led to an
mprovement in the confidence of interpretation. In
his regard, the current results are consistent with
revious data using a different contrast agent
12,13). However, to our knowledge, the present
tudy is the first to show, in the same patients
ndergoing DSE with and without the use of a
ontrast agent, that the improvement in image
uality and confidence of interpretation leads to an
mprovement in the diagnostic accuracy of DSE as
ompared to coronary angiography.
The impact of contrast agent use was related to
he extent of segment visualization and confidence
f interpretation of unenhanced studies. As visibil-
ty and confidence of interpretation decreased, a
reater impact of contrast agent use on improving
ccuracy was observed. In studies with high confi-
ence and where all segments were visualized at
est, there was no impact of contrast agent use as
xpected, with a possibility of degradation of image
uality. The impact of contrast agent use was
ighest in studies with poor visualization, inter-
reted with low confidence, and intermediate in the
oderate confidence group. The enhancement in
verall accuracy was a combination of improvement
n both sensitivity and specificity of detecting wall
otion abnormalities. Interestingly, the impact was
ore significant in both the CX and RCA territo-
ies compared with the LAD territory. This may be
ue to the extensiveness of the LAD territory in
eneral; consequently, any wall motion abnormality
ranslates into detection of disease and is easier
ecause the total or partial LAD territory can be
ssessed from all views. Another possible explana-
ion is the lesser definition and greater heterogene-
ty of wall motion in the cardiac base, crucial for
etection of non-LAD disease (18). No significant
ide effects were attributed to the use of a contrast
gent, similar to previous investigations of safety of
ontrast agent use during stress (19).
In the present study, we evaluated 2 parameters
f the technical quality of DSE: a confidence
core—a subjective assessment of the ability of the
eader to render an interpretation—and the number
f segments visualized—a more objective, semi-
uantitative parameter. In patients where all seg-
ents were visualized, there was no impact of
ontrast agent use on accuracy. However, with
orsening endocardial visualization, an increasing
mpact of contrast agent use was seen. In patients sith more than 2 nonvisualized segments or low
onfidence of interpretation, the impact was very
ignificant: the rate of agreement with angiography
mproved with either definition by 31% and 32%,
espectively. This group constituted 25% to 28% of
he patient population, which was not selected
ased on image quality. In the intermediate visual-
zation group (1 to 2 nonvisualized segments or
edium confidence, constituting another 21% to
1% of the population), accuracy improved less
ignificantly by 5% to 8%. A threshold of 2 or more
onvisualized segments is recommended for the use
f a contrast agent in the evaluation of regional and
lobal ventricular function by the American Society
f Echocardiography based on results from rest
tudies (20). The present investigation extends
hese observations to stress echocardiography and
emonstrates the importance of the use of a con-
rast agent for optimal DSE accuracy depending on
mage quality at rest.
tudy limitations. Patients with severe ventricular
ysfunction were excluded because the diagnosis of
AD is not an issue, whereas residual viability is.
he specificity of DSE for CAD is overall lower
han earlier published studies. Post-referral verifi-
ation bias, when coronary angiography is used as
he standard, may have contributed to this obser-
ation (21). Furthermore, microvascular disease
ay be present in some cases of ischemia with
onsignificant epicardial CAD because a large
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